Expanding understanding and care for dementia in Latino communities across Latin America and the US
Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat2)
This project brings together clinical exams, brain scans, and genetic tests from thousands of Latino people with Alzheimer’s disease, frontotemporal dementia, and healthy volunteers to improve diagnosis and care for Latino communities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11470977 on NIH RePORTER |
What this research studies
If I take part, researchers will enroll thousands of people in Argentina, Brazil, Chile, Colombia, Mexico, Peru, and the US, including people with Alzheimer's disease, frontotemporal lobar degeneration, and healthy controls. They will collect clinical information, cognitive testing, neuroimaging, and whole genome sequencing, and combine these new data with earlier ReDLat datasets. The team will look at how social and economic factors, family genetics, and brain changes shape dementia in Latino populations. Their goal is to create models that reflect the diversity of Latino communities so diagnosis and future treatments can be more accurate and fair for people like me.
Who could benefit from this research
Good fit: Ideal candidates are Latino adults in Argentina, Brazil, Chile, Colombia, Mexico, Peru, or the US who have Alzheimer’s disease or frontotemporal lobar degeneration, their family members for genetic studies, or healthy older Latino volunteers.
Not a fit: People who are not Latino or who cannot travel to participating sites, and those with health conditions that prevent MRI or genetic sampling, may not be eligible or directly benefit from this project.
Why it matters
Potential benefit: If successful, this work could lead to better, more culturally and genetically relevant diagnosis and care options for Latinos with Alzheimer’s disease or frontotemporal dementia.
How similar studies have performed: This builds on the original ReDLat effort and other multimodal dementia studies that have shown promise, but large-scale genetic and multimodal work specifically in Latino populations is still relatively novel.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Miller, Bruce L — University of California, San Francisco
- Study coordinator: Miller, Bruce L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.